BIOLASE Reports 2017 Second Quarter and Six-Month Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Biolase (BIOL) Misses Q2 EPS by 3c
August 7, 2017 4:16 PM EDTBiolase (NASDAQ: BIOL) reported Q2 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $14.15 million.
For earnings history and earnings-related data on Biolase (BIOL) click here.
... More